Aeroflow Health has acquired Canopie for an undisclosed amount, marking a significant expansion in its commitment to maternal health. Canopie is a comprehensive digital platform designed to prevent and treat maternal health conditions, identifying at-risk expecting and new mothers and connecting them with evidence-based, accessible care.
Canopie's platform offers extensive support for mothers, including comprehensive screening, asynchronous therapeutic programs, education, virtual expert and peer support, and continuous monitoring throughout the perinatal period, available in both English and Spanish. The platform also assists care partners by cost-effectively extending behavioral health resources and triaging patients, integrating with existing care flows and providing real-time data through a HIPAA and SOC-2 Type-2 compliant system. Canopie primarily engages expecting populations early in pregnancy, reaching thousands of mothers across the United States and through partners in the United Kingdom every month.
This acquisition is strategically aimed at enhancing Aeroflow Health's capabilities in providing holistic support for expecting and new mothers. By integrating Canopie's specialized digital tools and early intervention programs, Aeroflow Health seeks to strengthen its ability to identify and address maternal health challenges proactively. The synergy between Canopie's evidence-based care and Aeroflow Health's broader initiatives is expected to improve access to critical mental and behavioral health resources for a wider population.
The combined entity is poised to offer a more comprehensive continuum of care, ensuring that mothers receive timely and appropriate support throughout their perinatal journey. This move underscores a commitment to advancing maternal well-being through integrated, accessible, and effective digital health solutions.